Table 2. Prevalence of allergic disease, airway hyperresponsiveness, and allergic sensitization of the study subjects.
Total | Study region (%) | |||||
---|---|---|---|---|---|---|
n/N | % | Metropolitans | Industrial area | Rural area | P value | |
Wheeze, ever | 1,000/4,203 | 23.8 | 24.5 | 23.6 | 23.4 | 0.792 |
Wheeze, past year | 522/4,203 | 12.4 | 10.7 | 12.7 | 13.3 | 0.109 |
Diagnosed asthma, ever | 466/4,203 | 11.1 | 11.9 | 10.3 | 11.3 | 0.401 |
Asthma treatment, past year | 184/4,203 | 4.4 | 4.0 | 4.3 | 4.7 | 0.627 |
Allergic rhinitis symptoms, ever | 1,943/4,167 | 46.6 | 47.6 | 46.9 | 45.7 | 0.621 |
Allergic rhinitis symptoms, past year | 1,734/4,167 | 41.6 | 43.3 | 42.2 | 39.9 | 0.181 |
Diagnosed allergic rhinitis, ever | 1,076/4,167 | 25.8 | 28.8 | 28.6 | 21.0 | <0.001 |
Allergic rhinitis treatment, past year | 858/4,167 | 20.6 | 23.1 | 23.3 | 16.1 | <0.001 |
Airway hyperresponsiveness | ||||||
PC20≤8 mg/mL | 389/1,855 | 21.0 | 27.7 | 16.8 | 18.2 | <0.001 |
Allergic sensitization | ||||||
Any allergen positive | 420/1,254 | 33.5 | 36.7 | 33.6 | 29.7 | 0.129 |